 | Up a level |
2021
Diel, R., Schaberg, T., Nienhaus, A., Otto-Knapp, R., Kneitz, C., Krause, A., Fabri, M., Mrowietz, U., Bauer, T. and Haecker, B. (2021). Joint Statement (DZK, DGRh, DDG) on the Tuberculosis Risk with Treatment Using Novel Non-TNF-Alpha Biologicals. Pneumologie, 75 (4). S. 293 - 304. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
2014
Wolfson, L., Wirth, D., Jibbert, J., Diel, R. and Rutz, S. (2014). COSTS AND EFFECTIVENESS OF COMBINATION THERAPY WITH BEDAQUILINE AND OTHER ANTI-TUBERCULOSIS DRUGS IN PATIENTS WITH MULTI-AND EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS IN GERMANY. Value Health, 17 (7). S. A674 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733